1. Home
  2. Nation
  3. Govt approves Bharat biotech’s intranasal Covid vaccine as booster shots, added on CoWIN app from today

Govt approves Bharat biotech’s intranasal Covid vaccine as booster shots, added on CoWIN app from today

Two-drop nasal vaccine for Covid has also been approved by the government; Official sources said that those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.

By Ruchi Upadhyay 
Updated Date

New Delhi: The Union Health Ministry today said that mock drills will be conducted in hospitals across the country from Tuesday. Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for adults or those above 18 years of age, official sources said on Thursday.”

Also Read :- Security Forces Clash with Naxals in Chhattisgarh's Kanker: Search Operation Initiated

Also, two-drop nasal vaccine for Covid has been approved by the government. Official sources said that people who have taken Covishield and Covaxin They can take it as a heterologous booster. It has been included in the vaccination drive from today and will appear on the Cowin application. For the time being it will be available in private hospitals.

“The government of India has approved the Nasal vaccine. It will be used as a heterologous booster and will be available first in private hospitals. It will be included in Covid vaccination program from today,” official sources said.

Bharat biotech’s Nasal vaccine, being a needless jab, will be India’s first such booster dose. It can be administered to those above 18 years. Pricing of the vaccine will be decided soon and it will be made available in government and private facilities.

Ministry of Science recognised the vaccine as the ‘World’s first intra-nasal vaccine for COVID developed by India’. The vaccine has been developed in partnership with Washington University St Louis, which has designed and developed and evaluated it in preclinical studies for efficacy. Product development related to preclinical safety evaluation, large-scale manufacturing scale-up, formulation and delivery device development, including human clinical trials, were conducted by Bharat Biotech.

Also Read :- Anil Desai, Shiv Sena leader, summoned by EOW in fund withdrawal complaint by Shinde faction

The ministry said today, “There has been a trend – COVID starts spreading from China, Korea, Brazil and then comes to South Asia. It has reached India in 20-35 days. We have to be vigilant.”

Citing researchers, the health ministry said weak vaccines, under-vaccination, lack of natural immunity and the sudden lifting of restrictions contributed to the outbreak.

Union Health Minister Mansukh Mandaviya will hold a meeting with Health Ministers of States and Union Territories regarding rising Covid cases in some parts of the world. The meeting will be held today at 3 pm through video conferencing.

The product development and clinical trials were funded in part by the Government of India through the Department of Biotechnology’s, Covid Suraksha program.

Also Read :- ED raids 29 locations across Gujarat in connection with probe linked to Human Trafficking Syndicates
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...